These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 16507539)

  • 21. Systemic targeted delivery of antisense with perflourobutane gas microbubble carrier reduced neointimal formation in the porcine coronary restenosis model.
    Kipshidze NN; Porter TR; Dangas G; Yazdi H; Tio F; Xie F; Hellinga D; Fournadjiev J; Wolfram R; Seabron R; Waksman R; Abizaid A; Roubin G; Iyer S; Leon MB; Moses JW; Iversen P
    Cardiovasc Radiat Med; 2003; 4(3):152-9. PubMed ID: 14984716
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preclinical and early clinical experience with a biodegradable polymer-based, rapamycin-eluting, Indian drug-eluting coronary stent: the BIO-RAPID study.
    Bhargava B; Karthikeyan G; Shankar PB; Seth S; Singh S; Pr U; Lal AV; Mohanty M
    Indian Heart J; 2008; 60(3):228-32. PubMed ID: 19240312
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Experimental efficacy of an everolimus eluting cobalt chromium stent.
    Carter AJ; Brodeur A; Collingwood R; Ross S; Gibson L; Wang CA; Haller S; Coleman L; Virmani R
    Catheter Cardiovasc Interv; 2006 Jul; 68(1):97-103. PubMed ID: 16755598
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization.
    Finn AV; Joner M; Nakazawa G; Kolodgie F; Newell J; John MC; Gold HK; Virmani R
    Circulation; 2007 May; 115(18):2435-41. PubMed ID: 17438147
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neointimal formation following drug-eluting stents: physiology, timeline, and the influence of drug delivery systems.
    Young JJ
    Rev Cardiovasc Med; 2007; 8 Suppl 1():S3-10. PubMed ID: 17401309
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effects of uncontrolled hyperglycemia on thrombosis and formation of neointima after coronary stent placement in a novel diabetic porcine model of restenosis.
    Carter AJ; Bailey L; Devries J; Hubbard B
    Coron Artery Dis; 2000 Sep; 11(6):473-9. PubMed ID: 10966133
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug-eluting stents: preventing restenosis.
    Slavin L; Chhabra A; Tobis JM
    Cardiol Rev; 2007; 15(1):1-12. PubMed ID: 17172878
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative healing response after sirolimus- and paclitaxel-eluting stent implantation in a pig model of restenosis.
    Silva GV; Fernandes MR; Madonna R; Clubb F; Oliveira E; Jimenez-Quevedo P; Branco R; Lopez J; Angeli FS; Sanz-Ruiz R; Vaughn WK; Zheng Y; Baimbridge F; Canales J; Cardoso CO; Assad JA; Falotico R; Perin EC
    Catheter Cardiovasc Interv; 2009 May; 73(6):801-8. PubMed ID: 19309735
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stent-induced neutrophil activation is associated with an oxidative burst in the inflammatory process, leading to neointimal thickening.
    Inoue T; Kato T; Hikichi Y; Hashimoto S; Hirase T; Morooka T; Imoto Y; Takeda Y; Sendo F; Node K
    Thromb Haemost; 2006 Jan; 95(1):43-8. PubMed ID: 16543960
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Biodegradable polymer-coated - new step in coronary arteriosclerosis intervention].
    Siminiak T
    Kardiol Pol; 2010 May; 68(5):510-1. PubMed ID: 20491009
    [No Abstract]   [Full Text] [Related]  

  • 31. A novel paclitaxel-eluting porous carbon-carbon nanoparticle coated, nonpolymeric cobalt-chromium stent: evaluation in a porcine model.
    Bhargava B; Reddy NK; Karthikeyan G; Raju R; Mishra S; Singh S; Waksman R; Virmani R; Somaraju B
    Catheter Cardiovasc Interv; 2006 May; 67(5):698-702. PubMed ID: 16575925
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Restenosis related to percutaneous coronary intervention has been solved?
    Kivelä A; Hartikainen J
    Ann Med; 2006; 38(3):173-87. PubMed ID: 16720432
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Local paclitaxel delivery after coronary stenting in an experimental animal model.
    Dommke C; Haase KK; Süselbeck T; Streitner I; Haghi D; Metz J; Borggrefe M; Herdeg C
    Thromb Haemost; 2007 Sep; 98(3):674-80. PubMed ID: 17849059
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Local delivery of 17-beta-estradiol modulates collagen content in coronary porcine arteries after PTCA and stent implantation.
    Geraldes P; Geoffroy P; Cloutier I; Sirois MG; Tanguay JF
    J Vasc Res; 2008; 45(6):503-11. PubMed ID: 18451633
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intramural delivery of recombinant apolipoprotein A-IMilano/phospholipid complex (ETC-216) inhibits in-stent stenosis in porcine coronary arteries.
    Kaul S; Rukshin V; Santos R; Azarbal B; Bisgaier CL; Johansson J; Tsang VT; Chyu KY; Cercek B; Mirocha J; Shah PK
    Circulation; 2003 May; 107(20):2551-4. PubMed ID: 12742990
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low-energy gamma-emitting stents inhibit intimal hyperplasia with minimal "edge effects" in a pig coronary artery model.
    Kutryk MJ; Kuliszewski MA; Jaffe R; Tio FO; Janicki C; Sweet WL; Sparkes JD; Strauss BH
    Cardiovasc Revasc Med; 2007; 8(1):28-37. PubMed ID: 17293266
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fractured DES with a patent coronary artery: clinical implications.
    Park JS; Shin DG; Kim YJ
    J Invasive Cardiol; 2007 Feb; 19(2):E43-5. PubMed ID: 17268051
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Coronary artery stents: Part I. Evolution of percutaneous coronary intervention.
    Newsome LT; Kutcher MA; Royster RL
    Anesth Analg; 2008 Aug; 107(2):552-69. PubMed ID: 18633035
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Incomplete neointimal coverage of sirolimus-eluting stents: angioscopic findings.
    Kotani J; Awata M; Nanto S; Uematsu M; Oshima F; Minamiguchi H; Mintz GS; Nagata S
    J Am Coll Cardiol; 2006 May; 47(10):2108-11. PubMed ID: 16697331
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical outcomes after multilesion percutaneous coronary intervention: comparison between exclusive and selective use of drug-eluting stents.
    Bertrand OF; Faurie B; Larose E; Nguyen CM; Gleeton O; Déry JP; Noël B; Proulx G; Roy L; Costerousse O; De Larochellière R; Rodés-Cabau J
    J Invasive Cardiol; 2008 Mar; 20(3):99-104. PubMed ID: 18316823
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.